ADME Prediction, Structure-activity Relationship of Boswellic Acid Scaffold for the Aspect of Anticancer & Anti-inflammatory Potency

Anticancer Agents Med Chem. 2023;23(13):1499-1505. doi: 10.2174/1871520623666230417080437.

Abstract

Nature is the chief source of various remedies which are used to cure various diseases. Boswellic acid (BA) is a secondary metabolite from the pentacyclic terpenoid compound groups that are derived from the plant genus Boswellia. The oleo gum resins of these plants are primarily composed of polysaccharides, with the remaining amounts of resin (30-60%) and essential oils (5-10%) soluble in organic solvents. BA and its analogs are also reported to exhibit various in vivo and biological responses for example anti-inflammatory, anti-tumor, free radical scavenging activity, etc. Among all analogs, 11-keto-β-boswellic acid (KBA) and 3-O-acetyl-11-keto-β-boswellic acid (AKBA) has been demonstrated to be the most effective at reducing cytokine production and inhibiting the inflammatory responsecausing enzymes. In this review, we summarized the computational ADME prediction via the SwissADME computational tool and the structure-activity relationship of the Boswellic acid scaffold for the aspect of anticancer and antiinflammatory potency. In addition to these research findings which are associated with the therapy of acute inflammation and some cancers, the potential of boswellic acids against other disorders was also discussed.

Keywords: Natural remedies; SwissADME; anti-cancer; anti-inflammatory; boswellic acid; pentacyclic.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Boswellia*
  • Humans
  • Plant Extracts
  • Structure-Activity Relationship
  • Triterpenes* / metabolism
  • Triterpenes* / pharmacology

Substances

  • boswellic acid
  • Anti-Inflammatory Agents
  • Plant Extracts
  • Triterpenes
  • acetyl-11-ketoboswellic acid